VTRS Q2 2020 Earnings — Viatris Inc. Revenue & Financial Results | Market Cap Arena

VTRSViatris Inc.

$16B

Q2 2020 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$2.7B-4.2% YoY

Gross Profit

$1.0B37.6% margin

Operating Income

$134M4.9% margin

Net Income

$39M1.4% margin

EPS (Diluted)

$0.08

QoQ Revenue Growth

+4.3%

Cash Flow

Operating Cash Flow

$380M

Free Cash Flow

$326M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$30.2B

Total Liabilities

$18.4B

Stockholders' Equity

$11.7B

Cash & Equivalents

$324M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.7B	$2.9B	-4.2%
Gross Profit	$1.0B	$933M	+10.0%
Operating Income	$134M	$96M	+40.5%
Net Income	$39M	-$169M	+123.4%